• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然产生的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)缺陷干扰颗粒的进化

Evolution of naturally arising SARS-CoV-2 defective interfering particles.

作者信息

Girgis Samer, Xu Zaikun, Oikonomopoulos Spyros, Fedorova Alla D, Tchesnokov Egor P, Gordon Calvin J, Schmeing T Martin, Götte Matthias, Sonenberg Nahum, Baranov Pavel V, Ragoussis Jiannis, Hobman Tom C, Pelletier Jerry

机构信息

Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada.

Department of Cell Biology, U Alberta, Edmonton, AB, T6G 2H7, Canada.

出版信息

Commun Biol. 2022 Oct 27;5(1):1140. doi: 10.1038/s42003-022-04058-5.

DOI:10.1038/s42003-022-04058-5
PMID:36302891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9610340/
Abstract

Defective interfering (DI) particles arise during virus propagation, are conditional on parental virus for replication and packaging, and interfere with viral expansion. There is much interest in developing DIs as anti-viral agents. Here we characterize DI particles that arose following serial passaging of SARS-CoV-2 at high multiplicity of infection. The prominent DIs identified have lost ~84% of the SARS-CoV-2 genome and are capable of attenuating parental viral titers. Synthetic variants of the DI genomes also interfere with infection and can be used as conditional, gene delivery vehicles. In addition, the DI genomes encode an Nsp1-10 fusion protein capable of attenuating viral replication. These results identify naturally selected defective viral genomes that emerged and stably propagated in the presence of parental virus.

摘要

缺陷干扰(DI)颗粒在病毒传播过程中产生,其复制和包装依赖于亲代病毒,并会干扰病毒的扩增。人们对开发DI颗粒作为抗病毒药物很感兴趣。在此,我们对在高感染复数下连续传代的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)所产生的DI颗粒进行了表征。鉴定出的主要DI颗粒已丢失约84%的SARS-CoV-2基因组,并且能够降低亲代病毒滴度。DI基因组的合成变体也能干扰感染,可作为条件性基因传递载体。此外,DI基因组编码一种能够减弱病毒复制的Nsp1-10融合蛋白。这些结果鉴定出了在亲代病毒存在的情况下出现并稳定传播的自然选择的缺陷病毒基因组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/408ca2a3d938/42003_2022_4058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/0922c9aa1a09/42003_2022_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/841780f89cbf/42003_2022_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/505016467f06/42003_2022_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/f831706d40e3/42003_2022_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/408ca2a3d938/42003_2022_4058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/0922c9aa1a09/42003_2022_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/841780f89cbf/42003_2022_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/505016467f06/42003_2022_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/f831706d40e3/42003_2022_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d8/9613755/408ca2a3d938/42003_2022_4058_Fig5_HTML.jpg

相似文献

1
Evolution of naturally arising SARS-CoV-2 defective interfering particles.自然产生的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)缺陷干扰颗粒的进化
Commun Biol. 2022 Oct 27;5(1):1140. doi: 10.1038/s42003-022-04058-5.
2
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.甲型流感病毒及其缺陷干扰颗粒的半连续繁殖:分析动态竞争以选择抗病毒治疗候选物。
J Virol. 2021 Nov 23;95(24):e0117421. doi: 10.1128/JVI.01174-21. Epub 2021 Sep 22.
3
Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.流感病毒缺陷干扰粒子及其特性、影响及在疫苗和抗病毒策略中的应用:系统评价。
Viruses. 2022 Dec 12;14(12):2773. doi: 10.3390/v14122773.
4
Generation of Defective Interfering Particles of Morbilliviruses Using Reverse Genetics.利用反向遗传学生成麻疹病毒缺陷干扰颗粒。
Methods Mol Biol. 2024;2808:57-70. doi: 10.1007/978-1-0716-3870-5_5.
5
Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles.甲病毒的低保真聚合酶以更高的频率重组以过量产生缺陷干扰颗粒。
J Virol. 2015 Dec 16;90(5):2446-54. doi: 10.1128/JVI.02921-15.
6
Inhibition of Nipah Virus by Defective Interfering Particles.缺陷干扰颗粒抑制尼帕病毒。
J Infect Dis. 2020 May 11;221(Suppl 4):S460-S470. doi: 10.1093/infdis/jiz564.
7
A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.副粘病毒仙台病毒核蛋白内的单个氨基酸取代是产生诱导干扰素-β的回文型缺陷干扰基因组的关键决定因素。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.02094-17. Print 2018 Mar 1.
8
Persistent infection with human parainfluenza virus 3 in CV-1 cells: analysis of the role of defective interfering particles.CV-1细胞中人类副流感病毒3型的持续感染:缺陷干扰颗粒作用的分析
Virology. 1993 May;194(1):399-402. doi: 10.1006/viro.1993.1275.
9
Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.甲型 H1N1 流感大流行病毒体内缺陷干扰样 RNA 的序列分析。
J Virol. 2013 Jul;87(14):8064-74. doi: 10.1128/JVI.00240-13. Epub 2013 May 15.
10
Parallel ClickSeq and Nanopore sequencing elucidates the rapid evolution of defective-interfering RNAs in Flock House virus.平行ClickSeq和纳米孔测序揭示了鸡瘟病毒中缺陷干扰RNA的快速进化。
PLoS Pathog. 2017 May 5;13(5):e1006365. doi: 10.1371/journal.ppat.1006365. eCollection 2017 May.

引用本文的文献

1
Identification, functional analysis, and clinical applications of defective viral genomes.缺陷病毒基因组的鉴定、功能分析及临床应用
Front Microbiol. 2025 Jul 17;16:1642520. doi: 10.3389/fmicb.2025.1642520. eCollection 2025.
2
Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes.冠状病毒复制:基因组、亚基因组RNA和缺陷病毒基因组
Viruses. 2025 May 28;17(6):767. doi: 10.3390/v17060767.
3
Syncytium: the viral escape room secret to persistent infection of SARS-CoV-2.合胞体:SARS-CoV-2持续感染的病毒“密室逃脱”秘诀。

本文引用的文献

1
A defective viral genome strategy elicits broad protective immunity against respiratory viruses.一种有缺陷的病毒基因组策略能引发针对呼吸道病毒的广泛保护免疫。
Cell. 2021 Dec 9;184(25):6037-6051.e14. doi: 10.1016/j.cell.2021.11.023. Epub 2021 Nov 18.
2
Experimental and mathematical insights on the interactions between poliovirus and a defective interfering genome.实验和数学洞察脊髓灰质炎病毒与缺陷干扰基因组之间的相互作用。
PLoS Pathog. 2021 Sep 27;17(9):e1009277. doi: 10.1371/journal.ppat.1009277. eCollection 2021 Sep.
3
Molecular Determinants of SARS-CoV-2 Variants.
Front Microbiol. 2025 Jun 4;16:1561274. doi: 10.3389/fmicb.2025.1561274. eCollection 2025.
4
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals.规避传统抗病毒药物出现耐药性的策略与努力。
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
5
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内 SARS-CoV-2 宿主内基因进化特征分析
J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. Epub 2025 May 6.
6
Role of Defective Interfering Particles in Complement-Mediated Lysis of Parainfluenza Virus-Infected Cells.缺陷干扰颗粒在补体介导的副流感病毒感染细胞裂解中的作用
Viruses. 2025 Mar 28;17(4):488. doi: 10.3390/v17040488.
7
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内新冠病毒的宿主内基因进化特征分析
medRxiv. 2025 Mar 7:2025.03.03.25323296. doi: 10.1101/2025.03.03.25323296.
8
Antivirotics based on defective interfering particles: emerging concepts and challenges.基于缺陷干扰颗粒的抗病毒药物:新出现的概念与挑战。
Front Cell Infect Microbiol. 2025 Feb 24;15:1436026. doi: 10.3389/fcimb.2025.1436026. eCollection 2025.
9
Diverse effects of coronavirus-defective viral genomes on the synthesis of IFNβ and ISG15 mRNAs and coronavirus replication.冠状病毒缺陷病毒基因组对IFNβ和ISG15 mRNA合成及冠状病毒复制的多样影响。
Virol J. 2025 Feb 14;22(1):37. doi: 10.1186/s12985-025-02654-5.
10
SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染人多能干细胞衍生的血管细胞表明,平滑肌细胞是感染期间血管病理的关键介质。
Nat Commun. 2024 Dec 30;15(1):10754. doi: 10.1038/s41467-024-54917-4.
严重急性呼吸综合征冠状病毒2变种的分子决定因素
Trends Microbiol. 2021 Oct;29(10):871-873. doi: 10.1016/j.tim.2021.07.002. Epub 2021 Jul 27.
4
A synthetic defective interfering SARS-CoV-2.一种合成的缺陷干扰性严重急性呼吸综合征冠状病毒2。
PeerJ. 2021 Jul 1;9:e11686. doi: 10.7717/peerj.11686. eCollection 2021.
5
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.SARS-CoV-2 采用多管齐下的策略来阻碍宿主蛋白合成。
Nature. 2021 Jun;594(7862):240-245. doi: 10.1038/s41586-021-03610-3. Epub 2021 May 12.
6
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.缺陷型病毒基因组作为治疗性干扰颗粒对抗哺乳动物和蚊子宿主中黄病毒感染。
Nat Commun. 2021 Apr 16;12(1):2290. doi: 10.1038/s41467-021-22341-7.
7
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.来自基孔肯雅病毒的缺陷病毒基因组是广谱抗病毒剂,可防止病毒在蚊子中传播。
PLoS Pathog. 2021 Feb 8;17(2):e1009110. doi: 10.1371/journal.ppat.1009110. eCollection 2021 Feb.
8
The coronavirus proofreading exoribonuclease mediates extensive viral recombination.冠状病毒校对外切核糖核酸酶介导广泛的病毒重组。
PLoS Pathog. 2021 Jan 19;17(1):e1009226. doi: 10.1371/journal.ppat.1009226. eCollection 2021 Jan.
9
The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.SARS-CoV-2 的短程和长程 RNA-RNA 互作组。
Mol Cell. 2020 Dec 17;80(6):1067-1077.e5. doi: 10.1016/j.molcel.2020.11.004. Epub 2020 Nov 5.
10
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.SARS-CoV-2 的非结构蛋白 1 是一种强大的致病性因子,它将宿主蛋白合成机制引导到病毒 RNA 上。
Mol Cell. 2020 Dec 17;80(6):1055-1066.e6. doi: 10.1016/j.molcel.2020.10.034. Epub 2020 Oct 29.